This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

ACGL, Goldman: New Targets, Estimates

Stocks in this article: ACGL CLF CPB

Also see: Citi, Peabody: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES

Arch Capital (ACGL) estimates were cut through 2011 at UBS. Reflects an increase of the second-quarter 2011 catastrophe loss estimate, UBS said. Maintain Neutral rating and $34 price target.

Cliffs Natural Resources (CLF) estimates were increased through 2013 at UBS. Company announces phase III development of Bloom Lake, UBS said. Maintain Neutral rating and $34 price dtarget.

Campbell Soup (CPB) estimates, target were raised at Goldman Sachs. Shares now seen reaching $34, and estimates were also increased, as a restructuring program was announced, Goldman said. Neutral rating.

Goldman Sachs (GS) numbers were lowered through 2013 at Credit Suisse. Company is facing difficult market conditions, Credit Suisse said. Outperform rating and new $170 price target.

Harsco (HSC) price target was cut at Jefferies to $38. Infrastructure business is still a work in progress, Jefferies said. Buy rating.

Maidenform (MFB) estimates, target were lowered at Citigroup. Shares now seen reaching $38. Estimates were also lowered, as sales have not been as robust as expected, Citigroup said. Buy rating.

Morgan Stanley (MS) numbers were reduced at Credit Suisse. Shares now seen reaching $33. Estimates also cut, given tougher market conditions, Credit Suisse said. Outperform rating.

Nike (NKE) estimates, target raised at Citigroup. Shares now seen reaching $98, according to Citigroup. Estimates also increased on renewed apparel growth and innovation in footwear. Buy rating.

Progress Energy (PGN) target cut at Jefferies. Shares of PGN now seen reaching $48.50, according to Jefferies. Company could face delays at Crystal River, Jefferies said. Hold rating.

Rowan (RDC) estimates were cut through 2012 at UBS. Reflects closing of LTI sale and fleet status update. Maintain Buy rating and $50 price target.

Sigma Designs (SIGM) estimates, target were reduced at UBS. Shares now seen reaching $8.50. Estimates also lowered on IPTV segment recovery and sales mix uncertainties, UBS said. Maintain Neutral rating.

SYNNEX (SNX) estimates, target cut at Goldman Sachs. Shares now seen reaching $33. Estimates also lowered citing Japan weakness, Goldman said. Neutral rating.

Watson Pharmaceuticals (WPI) estimates, target raised at Morgan Stanley. Shares now seen reaching $78, according to Morgan Stanley. Estimates also increased on lower-than-expected royalties on Concerta and Specifar accretion, Morgan Stanley added. Overweight rating.

End of report.

This article was written by a staff member of TheStreet.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,674.01 +317.14 1.83%
S&P 500 2,045.87 +32.98 1.64%
NASDAQ 4,722.4210 +78.1090 1.68%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs